3.9(top 4%)
Impact Factor
4(top 4%)
extended IF
59(top 7%)
H-Index
648
authors
2K
papers
28.3K
citations
2.8K
citing journals
16.2K
citing authors
Selected Period:
-
Impact Factor of Cancer Biotherapy and Radiopharmaceuticals based on the number of citations over 2-year window
The graph shows the changes in the impact factor of Cancer Biotherapy and Radiopharmaceuticals and its the corresponding percentile for the sake of comparison with the entire literature. Impact Factor is the most common scientometric index, which is defined by the number of citations of papers in two preceding years divided by the number of papers published in those years.

How Influential is Cancer Biotherapy and Radiopharmaceuticals?

Cancer Biotherapy and Radiopharmaceuticals is the 60th out of 350 Radiology journals. This means the journal is among the top 18% in the discipline of Radiology. This Journal is the 136th out of 471 Oncology journals. This Journal is the 223rd out of 1,169 Pharmacology journals. This means the journal is among the top 20% in the discipline of Pharmacology. This Journal is the 1351st out of 8,993 Life Sciences journals. This means the journal is among the top 16% in the science branch of Life Sciences. This Journal is the 1471st out of 14,350 Health Sciences journals. This means the journal is among the top 11% in the science branch of Health Sciences.